EP2906219
Orvepitant til meðhöndlunar á langvinnum kláða
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.10.2013EP published:
7.8.2019EP application number:
13774189.8
EP translation filed:
29.10.2019Grant published:
15.3.2020EPO information:
European Patent Register
Max expiry date:
8.10.2033Expiry date:
8.10.2024
Title:
ORVEPITANT FOR THE TREATMENT OF CHRONIC PRURITUS
Timeline
Today
9.10.2013EP application
7.8.2019EP Publication
29.10.2019Translation submitted
15.3.2020Registration published
8.10.2024Expires
Owner
Name:
NeRRe Therapeutics LimitedAddress:
Stevenage Bioscience Catalyst, Office F25 Incubator Building, Gunnels Wood Road , SG1 2FX, Stevenage Herts, GB
Inventor
Name:
EMILIANGELO, RattiAddress:
StevenageHerts SG1 2FX, GB
Name:
MICHAEL, TrowerAddress:
StevenageHerts SG1 2FX, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261712499 PDate:
11.10.2012Country:
US
Classification
Categories:
A61K 31/495, A61P 17/04
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 25.9.2019
Expires: 8.10.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 8
Paid: 23.9.2020
Expires: 8.10.2021
Payer: Patice ehf.
Number: 9
Paid: 28.9.2021
Expires: 8.10.2022
Payer: Patice ehf.
Number: 10
Paid: 29.9.2022
Expires: 8.10.2023
Payer: Patice ehf.
Number: 11
Paid: 11.10.2023
Expires: 8.10.2024
Payer: Árnason Faktor ehf.